Corrigendum to "Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer"
- PMID: 38290614
- DOI: 10.1016/j.xphs.2024.01.014
Corrigendum to "Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer"
Erratum for
- 
  
  Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer.J Pharm Sci. 2021 Feb;110(2):876-887. doi: 10.1016/j.xphs.2020.11.005. Epub 2020 Nov 7. J Pharm Sci. 2021. PMID: 33166581
Publication types
LinkOut - more resources
- Full Text Sources
 
        